The Role of Wearables in Heart Failure
The Role of Wearables in Heart Failure
复制标题
DOI：
10.1007/s11897-020-00467-x
复制
发表时间：
2020-08-01
影响因子：
--
通讯作者：
Cowie, Martin R.
中科院分区：
文献类型：
--
作者：
Singhal, Arvind;Cowie, Martin R.
审查的目的-这篇评论讨论了如何可穿戴设备传感器外部施加到身体测量的生理信号-可以用于心力衰竭（HF）Career.Recent Findings大多数可穿戴设备销售给消费者，可以测量运动，心率和血压;检测和监测心律失常;和支持运动训练和康复。针对医疗保健专业人员的可穿戴设备包括ECG贴片记录仪和背心、贴片和具有内置传感器的纺织品，用于改善急性失代偿的早期检测和早期检测。由于临床惰性和对数据安全性和有效性的担忧，缺乏有意义的影响证据，互操作性，监管和报销问题以及法律的责任，将可穿戴设备的数据整合到临床决策中的速度很慢。总结尽管很少有研究评估如何最好地将可穿戴技术整合到临床实践中，它们的使用正在迅速扩展，并且可以支持患者和健康护理专业人员沿着整个患者路径做出改进的决策。
Purpose of Review This review discusses how wearable devices-sensors externally applied to the body to measure a physiological signal-can be used in heart failure (HF) care.Recent Findings Most wearables are marketed to consumers and can measure movement, heart rate, and blood pressure; detect and monitor arrhythmia; and support exercise training and rehabilitation. Wearable devices targeted at healthcare professionals include ECG patch recorders and vests, patches, and textiles with in-built sensors for improved prognostication and the early detection of acute decompensation. Integrating data from wearables into clinical decision-making has been slow due to clinical inertia and concerns regarding data security and validity, lack of evidence of meaningful impact, interoperability, regulatory and reimbursement issues, and legal liability.Summary Although few studies have assessed how best to integrate wearable technologies into clinical practice, their use is rapidly expanding and may support improved decision-making by patients and healthcare professionals along the whole patient pathway.